Press release
Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo
The Key Alagille Syndrome Companies in the market include - Takeda, Mirum Pharmaceuticals, Albireo, and others.The Alagille Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alagille Syndrome pipeline products will significantly revolutionize the Alagille Syndrome market dynamics.
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Alagille Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Alagille Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alagille Syndrome Market Insights [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Alagille Syndrome Market Report:
*
The Alagille Syndrome market size is anticipated to grow with a significant CAGR during the study period (2020-2034).
*
In April 2025, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet version of LIVMARLI Registered (maralixibat) for treating cholestatic pruritus in patients with Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC).
*
In February 2025, A meta-analysis of four clinical trials suggests that Livmarli (maralixibat) and Bylvay (odevixibat) may alleviate itching (pruritus) and help lessen liver damage in children diagnosed with progressive familial intrahepatic cholestasis (PFIC) or Alagille syndrome.
*
DelveInsight's analysis estimates that the total prevalent cases of Alagille Syndrome (ALGS) across the 7MM were approximately 17,883 in 2023, with a projected increase throughout the forecast period (2024-2034). This growth is attributed to rising awareness and population expansion, leading to a higher prevalence of ALGS.
*
Germany reported the highest proportion of ALGS cases among the EU4 and the UK, while Spain had the lowest number of cases.
*
In 2023, the gender-specific cases of ALGS in the US were approximately 3,846 for males and 2,978 for females, with numbers anticipated to rise during the forecast period (2024-2034).
*
DelveInsight's experts analyzed the age-specific cases of ALGS, categorizing them into 0-0.5 years, 0.5-10 years, 11-20 years, and >20 years. In 2023, the highest number of cases (~4,436) was recorded in the 0.5-10 year age group in the US.
*
DelveInsight's estimates categorized the prevalence of ALGS based on its type into patients with chronic cholestasis and those without. In 2023, Japan reported a higher number of cases in patients with chronic cholestasis, with approximately 1,177 cases.
*
Key Alagille Syndrome Companies: Takeda, Mirum Pharmaceuticals, Albireo, and others
*
Key Alagille Syndrome Therapies: TAK-625, Maralixibat, Odevixibat, and others
*
The Alagille Syndrome epidemiology based on gender analyzed that Alagille Syndrome affects males and females in equal numbers
Alagille Syndrome Overview
Alagille Syndrome (ALGS) is a multisystem autosomal dominant disorder with a wide variety of clinical manifestations. It is also known as arteriohepatic dysplasia, Alagille-Watson syndrome, Watson-Miller syndrome or syndromic bile duct paucity.
Get a Free sample for the Alagille Syndrome Market Report
https://www.delveinsight.com/report-store/alagille-syndrome-market [https://www.delveinsight.com/report-store/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Alagille Syndrome Market
The dynamics of the Alagille Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
"Of the emerging therapies, the most anticipated product to get launched in the near future includes Odevixibat (Albireo). Odevixibat have also received Orphan Designation."
Alagille Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Alagille Syndrome Epidemiology Segmentation:
The Alagille Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Alagille Syndrome
*
Prevalent Cases of Alagille Syndrome by severity
*
Gender-specific Prevalence of Alagille Syndrome
*
Diagnosed Cases of Episodic and Chronic Alagille Syndrome
Download the report to understand which factors are driving Alagille Syndrome epidemiology trends @ Alagille Syndrome Epidemiological Insights [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Alagille Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alagille Syndrome market or expected to get launched during the study period. The analysis covers Alagille Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alagille Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Alagille Syndrome Therapies and Key Companies
*
Odevixibat: Albireo, an Ipsen Company
*
TAK-625: Takeda
*
Maralixibat: Mirum Pharmaceuticals
To know more about Alagille Syndrome treatment, visit @ Alagille Syndrome Medications [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Alagille Syndrome Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Alagille Syndrome Companies: Takeda, Mirum Pharmaceuticals, Albireo, and others
*
Key Alagille Syndrome Therapies: TAK-625, Maralixibat, Odevixibat, and others
*
Alagille Syndrome Therapeutic Assessment: Alagille Syndrome current marketed and Alagille Syndrome emerging therapies
*
Alagille Syndrome Market Dynamics: Alagille Syndrome market drivers and Alagille Syndrome market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Alagille Syndrome Unmet Needs, KOL's views, Analyst's views, Alagille Syndrome Market Access and Reimbursement
Discover more about therapies set to grab major Alagille Syndrome market share @ Alagille Syndrome Treatment Landscape [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Alagille Syndrome Market Report Introduction
2. Executive Summary for Alagille Syndrome
3. SWOT analysis of Alagille Syndrome
4. Alagille Syndrome Patient Share (%) Overview at a Glance
5. Alagille Syndrome Market Overview at a Glance
6. Alagille Syndrome Disease Background and Overview
7. Alagille Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Alagille Syndrome
9. Alagille Syndrome Current Treatment and Medical Practices
10. Alagille Syndrome Unmet Needs
11. Alagille Syndrome Emerging Therapies
12. Alagille Syndrome Market Outlook
13. Country-Wise Alagille Syndrome Market Analysis (2020-2034)
14. Alagille Syndrome Market Access and Reimbursement of Therapies
15. Alagille Syndrome Market Drivers
16. Alagille Syndrome Market Barriers
17. Alagille Syndrome Appendix
18. Alagille Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=alagille-syndrome-market-to-evolve-rapidly-over-the-next-decade-by-2034-delveinsight-observes-takeda-mirum-pharmaceuticals-albireo]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo here
News-ID: 4166946 • Views: …
More Releases from ABNewswire

DanceUs.org Announces Major Platform Updates to Enhance User Experience and Disc …
DanceUs.org, a Los Angeles-based online dance portal, has announced significant updates to its website following extensive user testing. The platform has revamped its calendar and improved its event and class navigation to make it easier for users to discover local dance activities. The company invites the public to explore the new features to find dance classes and events nearby.
LOS ANGELES, CA - October 2, 2025 - DanceUs.org, the leading online…

CrownPoint Partners Brokers $11.5 Million Sale of Newly Constructed Tractor Supp …
NAPLES, Fla. - CrownPoint Partners is pleased to announce the sale of a newly constructed Tractor Supply Co. property in Naples, Florida, for $11.5 million.
Managing Partners Shannon Bona and Julius Swolsky of CrownPoint Partners represented the seller, a prominent developer based in the Southeast. The buyer, a private 1031 exchange investor from the Midwest, was represented by David Weinberg of Marcus & Millichap.
The asset is a brand-new prototype Tractor Supply…

Biliary Tract Cancer Market Expected to Gain Momentum Through 2034, According to …
The Key Biliary Tract Cancer Companies in the market include - Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Inc., Boehringer Ingelheim, ZielBio, Inc., GeneQuantum Healthcare (Suzhou) Co., Ltd., BioNTech SE, SOTIO Biotech, Carisma Therapeutics Inc, Rain Oncology Inc, Avacta Life Sciences Ltd, DualityBio Inc., and others.
DelveInsight's "Biliary Tract Cancer Market Insights, Epidemiology, and Market…

Le Perle introduces Poland's first dental concierge service, elevating patient e …
Le Perle in Poznan launches the first dental concierge service in Poland, offering travel coordination, luxury stays, cultural experiences, and remote treatment monitoring.
Poznan, Poland - Le Perle , the boutique dental atelier led by Dr. Anna Kusnierczak ( Stomatolog Dobra Rada ), has announced the launch of Poland's first dental concierge [https://www.leperle.pl] service, redefining the way patients experience comprehensive treatment. This innovation integrates dentistry with tailored lifestyle services, further strengthening…
More Releases for Alagille
Alagille Syndrome Market is Set to Experience a Revolutionary Growth
Alagille Syndrome market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Alagille Syndrome Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Alagille Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Alagille Syndrome Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Alagille Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alagille Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Alagille Syndrome Research.…
Alagille Syndrome Drugs Market Size 2032| Clinical Trials, Emerging Drugs, and C …
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Alagille Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Alagille Syndrome market size from…
Alagille Syndrome Market Analysis and Future Prospects for 2030
The world of the alagille syndrome market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.…
Alagille Syndrome Market will exhibit a CAGR of around 6.62% by 2028
A worldwide Alagille Syndrome market report is the best to know the trends and opportunities in Healthcare industry. The forecast, analysis, evaluations and estimations carried out in this business report are all based upon the well established tools and techniques such as SWOT analysis and Porter's Five Forces analysis. These are the authentic tools used in market analysis on which businesses can trust confidently. The credible Alagille Syndrome market research…
Alagille Syndrome Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Alagille Syndrome market report provides current treatment practices, emerging drugs, Alagille Syndrome market share of the individual therapies, and current and forecasted Alagille Syndrome market size…